Buy the full study
Summary of our market study
In France, the home medical assistance market is estimated at 4 billion euros.
The global home healthcare market, valued at $282 billion, is expected to grow at an average annual rate of 8%.
In France, during the Covid-19 crisis, homecare providers cared for around 30,000 patients, despite a loss in sales of 200 million euros due to the postponement of treatment for chronic illnesses.
Demand is being driven by an aging population, with an estimated 2 million people a year using homecare services, 50% of whom suffer from sleep apnea and 19% of whom are elderly dependents. The number of people aged over 75 is expected to reach between 10 and 15 million by 2060.
More than half of people over 85 suffer from multiple chronic illnesses requiring constant care.
Two-thirds of the French population would prefer not to live in care facilities.
These services are indispensable for people suffering from chronic respiratory difficulties, sleep apnea, diabetes, Parkinson's disease and other pathologies requiring continuous medical monitoring.
The number of patients benefiting from home medical assistance is set to increase by 5-7% a year.
Progress has made it possible to treat at home a greater number of pathologies, such as cystic fibrosis and certain cancers, which previously required hospital stays.
Some 35% to 40% of people from the middle and upper classes claim to suffer from chronic health problems, and 45% to 50% among those from the working classes.
The main players in the French homecare market
- Air Liquide Santé: Air Liquide Santé has acquired Sleep & Health, specializing in sleep apnea, and Megamed, specializing in respiratory insufficiency. Air Liquide Santé is exploiting the potential of technology with initiatives such as "Chronic care connect", a system designed for remote monitoring and support of patients suffering from chronic illnesses.
- Bastide Group: The listed Group is recognized for its range of services beyond equipment rental and sales.
- Orkyn': A subsidiary of Air Liquide Santé, Orkyn' operates in the respiratory therapy market
- Elivie has developed its market presence through partnerships with clinics, healthcare establishments and retirement home managers.
- SOS Oxygène focuses on the needs of patients requiring respiratory assistance
- Proximed operates on a franchise model
to understand this market
Detailed content of our market study
Inforamtion
- Number of pages : ~ 40 pages
- Format : Digital and PDF versions
- Last update :
Summary and extracts
1 Market overview
1.1 Definition and scope of the study
Medical assistance at home is a practice of allowing patients to receive medical care in their own homes. The duration and therapeutic conditions of home care are defined by a health professional. This type of service is intended for people who are dependent, disabled or suffering from certain pathologies or health problems.
Home assistance generally requires the use of medical equipment, but differs from HAH (hospitalization at home) in that it involves less intensive care. The illnesses treated include chronic illnesses requiring recurrent treatment (chronic obstructive pulmonary disease, sleep apnoea, diabetes, Parkinson's disease, etc.).
The French home medical assistance market is growing, particularly due to the ageing of the population, which favours the appearance of numerous private structures. One of the major opportunities of the eastern sector technological progress (remote monitoring, connected medical equipment, etc.) which promises to be a growth lever in the years to come.
There is a great diversity of players on the market such as SOS Oxygen, Bastide Group or Air Liquide via various subsidiaries such as Orkyn' or LVL Medical. The market has undergone significant consolidation in recent years, which may continue in the future.
The staffing needs in this sector of the home health care providers (PSAD) are growing, with an average annual increase of 6% in recent years.
During the Covid-19 crisis, HHCP players were important in treating patients at home or in nursing homes, with an investment of €8 million in new concentrators in 2020. Nevertheless, the postponement of the treatment of certain chronic patients has affected the activity of the players.
1.2 A growing global market
The home care market is a growing market globally. The market is estimated to be worth $*** billion globally in **** and is expected to grow at an average rate of *.*% per annum to ****.
The ageing of the population is a major factor in this growth, as is the access of more and ...
1.3 A dynamic French market
In ****, Les Echos estimated in **** the market to be worth €*.* billion, with an average annual growth rate of *% in recent years.
In ****, according to the Federation of home care providers (***), the market size is to be €* billion, proof of the strong growth of the sector in recent years.
The Federation also ...
1.5 The ambivalent impact of the Covid-19 crisis
The positive impact related to the management of Covid-** patients:
From the beginning of the health crisis to November ****, **,*** Covid-** patients were managed by PSAD. The home health care providers also helped the nursing homes with their services.
Players have also sought to integrate remote monitoring processes with connected medical ...
2 Analysis of the demand
2.1 Patients managed by home health care
Approximately * million people a year use the services of the home health care providers (***).
The reasons for using PSAD services are diverse, but dominated by a few types of pathologies:
**% of patients have sleep apnoea ** % are dependent elderly people (***) *% are patients with disabilities
Patients treated by home medical assistance by ...
2.2 The ageing of the French population and dependent persons
A structural dynamic: the ageing of the population
The first reason for the good health of the home health care sector is the ageing of the French population.
Indeed, life expectancy in France in **** was **.* years compared to ** years in ****, an increase of about *% in ** years.
In ****, ** million people are expected ...
2.3 Chronic diseases or health problems in France
Chronic or long-lasting diseases or health problems develop mainly in the oldest people and among people in the most precarious living conditions.
Thus, on average, **.*% of the French middle and upper classes have chronic or long-lasting illnesses or health problems, in comparison to the **.*% of French people from the more working ...
2.4 French people's perception of home health care providers
Harris-interactive conducted a survey for Orkyn' in **** among *,*** people in October **** using the quota method in order to perceive the French people's knowledge and vision of home health care providers.
Confused knowledge of the areas and diseases covered by home health care providers:
The survey below highlights that the French do ...
2.5 Focus on sleep apnoea: the largest market segment
Sleep apnoea is also called obstructive sleep apnoea-hypopnea syndrome (***) breathing during sleep, depending on Ameli.
This causes a lack of oxygen, which causes the person to wake up to catch their breath. Sleep is then no longer restful, which can cause significant health problems.
Approximately *% of French people suffer from OSA, ...
3 Market structure
3.1 Forces at work
Home health care providers (***).
Among the home health care providers that have received the label are:
Bastide Orkyn AADAIRC Agir à domicile Alliance Soins Proximed Santélys Santélynes
They offer a wider range of services than the rental or purchase of medical equipment. They provide personalized support, taking into account the ...
3.2 Stakeholder strategy
The following are some (***) examples of competitive strategies pursued by the players.
M&A: to enter new markets (***) or to strengthen the treatment of a disease
In ****, Air Liquide (***) while developing "Chronic care connect ": a system for remote home medical monitoring and support for patients suffering from chronic diseases.
Partnership with ...
3.3 ADSP Value Chain
The various PSAD stakeholders
The chain of stakeholders involved in PSAD can vary greatly in size and nature.
In the treatment of complex chronic diseases such as cancer, the chain of medical actors involved in the PSAD can be very important prescribing oncologists, coordinating physicians, pharmacists from in-house pharmacies, health managers, ...
3.4 Employment dynamics and structure in the sector
According to Fedepsad, there are more than **,*** employees in the PSAD sector, of which approximately **% are health professionals, divided between:
Pharmacists Dieticians / nutritionists Nurses Masseurs - physiotherapists
The need for personnel is growing, especially for health professionals, according to the PSAD federation. This is *% per year on average.
These employees are ...
3.5 Home help: evolution of companies and employees in the sector
Home help is not part of the home health care providers sector, but is a complementary activity that some companies in the sector can (***) provided to the elderly and disabled. It also includes assistance in collective accommodation and in rural areas. Both companies and employees have seen a sharp increase in ...
4 Analysis of the offer
4.1 Pricing according to the type of structure and care
The French government is banking on the development of the home medical assistance sector thanks to the reimbursement of medical services included in the LPPR list (***) and thanks to the aid offered in certain cases.
The objective of the State, behind the development of this sector, is to fight against overcrowding ...
4.2 Services and care
The various business segments of the home health care providers can be grouped into four categories below.
Home support:
The market for home care services is therefore more essential than ever to guarantee a comfortable life and medical assistance to dependent people. The maintenance of the person at home is done ...
4.3 A market driven by technological innovation
E-health and technological progress as growth drivers
The e-health sector has been very dynamic in recent years. There is a **% growth between **** and **** worldwide, with more numerous fundraising events. According to a study by the start-up Health, all the young players in the sector had raised over $** billion in *** fundraisings in ...
5 Regulation
5.1 Regulations in force
Article L.***-* of the Social Security Code defines the List of Reimbursable Products and Services (***). To be reimbursed by social security, a medical service must be considered essential in the therapeutic process. The registration of a service on the LPPR must have a proven therapeutic interest and be approved by ...
6 Positioning of the actors
6.1 Segmentation
- Isis Medical
- Orkyn (Air liquide)
- Bastide Groupe
- LVL Medical (Air liquide)
- Vitalaire (AIR Liquide)
- SOS Oxygène
- Homeperf
- Bestens umsorgt (KORIAN Group)
- Laboratoires Euromedis
- Medic Alliance
- e-device
- Cap Vital Santé
- La vitrine médicale
- MyMobility
- Air Liquide
- Linde
- Vitame
- DomusVi Domicile
- Proximed Services
- Vitalliance
- Domaliance
- Dinno Santé
List of charts presented in this market study
- Size of the home health care market
- Sales of home healthcare service providers
- Impact of the Covid-19 crisis on PSAD
- Patients treated by home medical assistance by type of assistance
- Change in the proportion of French people aged over 60
All our studies are available online in PDF format
Take a look at an example of our research on another market!
Latest news
Air Liquide, another key player in the world of semiconductors - 03/06/2024
- - Air Liquide holds a quarter of the world market for gases used in semiconductor production.
- - In 2023, this activity generated 2.5 billion euros in sales for Air Liquide, representing 9% of its annual revenues.
- - The global semiconductor market could reach $1,000 billion by 2030, up from $520 billion last year.
- - Last week, Air Liquide inaugurated a new production line in Sejong, south of Seoul, dedicated to the manufacture of diborane, a complex molecule demanded by the sector's giants.
- - Air Liquide's two recent projects in the semiconductor sector, including the opening of a new plant in Taiwan, represented an investment of $200 million.
Air Liquide buoyed by energy transition and electronics - 20/02/2024
- Sales of 27.61 billion euros in 2023.
- Gases and services account for 95% of revenues
- Air Liquide has generated growth worldwide.
- In hydrogen, investment of 400 million euros in the construction of Europe's largest electrolyzer, Normand'Hy
- Inauguration with Siemens Energy of an electrolyser gigafactory in Berlin.
- 200 million investment in two new advanced materials production centers in Taiwan and South Korea
- 140 million investment in the construction of an air separation unit in Quebec, specializing in electric batteries.
Hydrogen: Air Liquide to build a giant electrolyser in Normandy - 21/12/2023
- Electrolyser capacity in Normandy: 200 megawatts (MW)
- Planned hydrogen production: 80 tonnes / day
- Amount of Air Liquide project: 400 million euros (Subsidies received for the project: 190 million euros)
- Air Liquide sales: 30 billion euros
- Air Liquide's target for electrolysis capacity increase by 2030: 3 gigawatts (GW)
- Current production capacity of the Berlin gigafactory in partnership with Siements Energy: 1 GW
- Hydrogen production from an electrolyser in Canada starting up in 2021: 8.2 tonnes / day
- Electrolyser nearing completion in Oberhausen (Germany): 30 MW
- Air Liquide's hydrogen experience: 60 years with over 200 stations and 350 production units.
Siemens Energy and Air Liquide inaugurate their gigafactory to get green hydrogen off the ground - 09/11/2023
- Siemens Energy and Air Liquide's electrolyser Gigafactory in Berlin.
- It will produce cells with a total capacity of 1GW in the first year, gradually increasing to 3GW.
- Investment of 30 million euros
- it will power the hydrogen projects of Siemens Energy and Air Liquide, its only two customers.
- In Germany, Air Liquide will commission a 20 MW plant in the Ruhr, currently the largest in Europe.
- Another electrolyzer, ten times larger (200 MW), is planned: "Normand'Hy".
- It will supply green hydrogen to manufacturers in the Seine Valley. TotalEnergies has already reserved half the capacity.
- Air Liquide plans to have a portfolio of 3 GW by 2030.
- Air Liquide currently produces 1.2 million tonnes of hydrogen a year worldwide, but the overwhelming majority is still of fossil origin.
- "By 2030, grey hydrogen may account for only 50% of our business,
- The group plans to triple its sales by 2035, to 6 billion euros, taking advantage of the growth in low-carbon hydrogen.
- Germany sees hydrogen as one of the main vectors for decarbonization.
- Hydrogen infrastructure plan in the coming weeks - a 10,000-kilometer network
Air Liquide greenens its hydrogen - 31/07/2023
- Air Liquide's Port-Jérôme plant captures 100,000 tonnes of CO2 each year, more than 90% of the plant's emissions.
- Air Liquide has received 200 million euros from the French government to launch a hydrogen industry in Normandy.
- 95% of the natural gas consumed at Port-Jérôme is transformed into hydrogen.
- The Normand'Hy project involves an investment of 250 million euros to build a 200-megawatt electrolyzer.
- More than 680 "large-scale" hydrogen projects have been announced worldwide, representing a total investment of $240 billion.
Air Liquide: the springboard of the energy crisis - 16/02/2023
- The Group reported annual sales of 29.93 billion euros, the highest in its history
- Sales were driven by industrial merchant activities, in particular hydrogen and oxygen sales to the steel and chemical industries in Europe and the United States
- three new industrial gas production units for two major semiconductor manufacturers in Taiwan
- The Group has built its largest biomethane production unit in the United States
Companies quoted in this study
This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :
Choosing this study means :
Access to more than 35 hours of work
Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.
Benefit from 6 years' experience and over 1,500 industry reports already produced
Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.
Our know-how and methodology enable us to produce reports that offer unique value for money.
Access to several thousand articles and paid-for data
Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).
To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)
Guaranteed support after your purchase
A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676
A digital format designed for our users
Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.
Our offers :
the home medical assistance market | France
- What are the figures on the size and growth of the market?
- What is driving the growth of the market and its evolution?
- What is the positioning of companies in the value chain?
- Data from several dozen databases
Pack 5 études (-15%) France
- 5 études au prix de 75,6€HT par étude à choisir parmi nos 800 titres sur le catalogue France pendant 12 mois
- Conservez -15% sur les études supplémentaires achetées
- Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)
Consultez les conditions du pack et de remboursement des crédits non consommés.
Our customer references
They have consulted our studies
Discover the opinions (+500)
Malcolm Vincent
Astoria Finance
Gregoire de Castelnau
Stags Participations
Timothé Huignard
PWC
Paul-Alexis Kebabtchieff
BCG
Aymeric Granet
Publicis Consultant
interviews & case studies
All interviews and case studies (45)
